{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:30:27Z","timestamp":1792251027806,"version":"4.4.0"},"reference-count":15,"publisher":"Bioscientifica","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Although bisphosphonates (BPs) are mainly used for the treatment of osteoporosis and are generally safe, long-term use and more dosage as utilised in malignant conditions may be associated with the rare adverse event of an atypical femoral fracture (AFF). Occasionally, the risk of developing an AFF persists long after BPs are withdrawn. A 39-year-old woman who underwent chemotherapy and an autologous stem cell transplantation for multiple myeloma presented to us with history of pain in the left thigh. She had received multiple doses of oral and parenteral BPs for about 10 years in view of the underlying myeloma with osteoporosis. Her investigations showed a suppressed CTX of 192 pg\/mL, and radiograph of pelvis displayed thickened cortices with beaking of the left femoral shaft, which was suggestive of an AFF. Following discontinuation of BPs, she underwent prophylactic intra-medullary nailing with which her symptoms improved. Five years later, she presented with similar complaints on the right side. Investigations showed that her bone turnover continued to be suppressed with Cross linked C- Telopeptide of type 1 collagen (CTX) of 165 pg\/mL and an X-ray done showed AFF on the right side despite being off BPs. A second intra-medullary nailing was done and on follow-up, she has been symptom-free and independent in her daily activities. Discontinuation of BPs may not prevent the incident second AFF and, therefore, thus warranting long-term follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Regular screening and follow-up of patients who receive long-term bisphosphonate (BP) therapy should be done.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Discontinuation of BPs does not preclude the possibility of repeated occurrence of a second AFF.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Long-term BP therapy warrants regular monitoring and follow-up should an AFF occur<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-22-0249","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:06:30Z","timestamp":1661335590000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":3,"title":["Bisphosphonate-induced atypical femoral fracture in tandem: long-term follow-up is warranted"],"prefix":"10.1530","volume":"2022","author":[{"given":"Mohammed Anwar","family":"Hussain","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Christian Medical College and Hospital, Vellore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneez","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Christian Medical College and Hospital, Vellore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinoo Mathew","family":"Cherian","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Christian Medical College and Hospital, Vellore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Haematology, Christian Medical College and Hospital, Vellore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kripa Elizabeth","family":"Cherian","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Christian Medical College and Hospital, Vellore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Christian Medical College and Hospital, Vellore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-341X","authenticated-orcid":true,"given":"Thomas Vizhalil","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Christian Medical College and Hospital, Vellore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"JAMA","first-page":"785","article-title":". Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy.. Osteoporosis prevention, diagnosis, and therapy. JAMA2001285785\u2013795. (https:\/\/doi.org\/10.1001\/jama.285.6.785)"},{"key":"bib2","series-title":"Indian Journal of Medical Research","first-page":"46","article-title":"Predictors of atypical femoral fractures during long term bisphosphonatetherapy: a case series and review of the literature","volume":"140","author":"Bhadada","year":"2014","unstructured":"Bhadada SKSridhar SMuthukrishnan JMithal ASharma DCBhansali ADhiman V. Predictors of atypical femoral fractures during long term bisphosphonatetherapy: a case series and review of the literature. Indian Journal of Medical Research201414046\u201354."},{"key":"bib3","series-title":"Journal of Bone and Mineral Research","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","unstructured":"Shane EBurr DAbrahamsen BAdler RABrown TDCheung AMCosman FCurtis JRDell RDempster DWAtypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research2014291\u201323. (https:\/\/doi.org\/10.1002\/jbmr.1998)10.1002\/jbmr.1998"},{"key":"bib4","series-title":"Osteoporosis International","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","unstructured":"Cosman Fde Beur SJLeBoff MSLewiecki EMTanner BRandall SLindsay R. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporosis International2014252359\u20132381.10.1007\/s00198-014-2794-2"},{"key":"bib5","series-title":"Mayo Clinic Proceedings","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","unstructured":"Drake MTClarke BLKhosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clinic Proceedings2008831032\u20131045. (https:\/\/doi.org\/10.4065\/83.9.1032)10.4065\/83.9.1032"},{"key":"bib6","series-title":"BMJ","article-title":"Bisphosphonates for the prevention and treatment of osteoporosis","volume":"351","author":"Maraka","year":"2015","unstructured":"Maraka SKennel KA. Bisphosphonates for the prevention and treatment of osteoporosis. BMJ2015351 h3783. (https:\/\/doi.org\/10.1136\/bmj.h3783)"},{"key":"bib7","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","unstructured":"Odvina CVZerwekh JERao DSMaalouf NGottschalk FAPak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. Journal of Clinical Endocrinology and Metabolism2005901294\u20131301. (https:\/\/doi.org\/10.1210\/jc.2004-0952)10.1210\/jc.2004-0952"},{"key":"bib8","series-title":"Journal of Biomechanics","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jbiomech.2015.01.032","article-title":"American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures","volume":"48","author":"Geissler","year":"2015","unstructured":"Geissler JRBajaj DFritton JC. American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures. Journal of Biomechanics201548883\u2013894. (https:\/\/doi.org\/10.1016\/j.jbiomech.2015.01.032)10.1016\/j.jbiomech.2015.01.032"},{"key":"bib9","series-title":"Bone","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","unstructured":"Mashiba TTurner CHHirano TForwood MRJohnston CCBurr DB. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone200128524\u2013531. (https:\/\/doi.org\/10.1016\/s8756-3282(0100414-8)10.1016\/S8756-3282(01)00414-8"},{"key":"bib10","series-title":"World Journal of Orthopedics","doi-asserted-by":"publisher","first-page":"660","DOI":"10.5312\/wjo.v12.i9.660","article-title":"Current concepts in the management of bisphosphonate associated atypical femoral fractures","volume":"12","author":"Rudran","year":"2021","unstructured":"Rudran BSuper JJandoo RBabu VNathan SIbrahim EWiik AV. Current concepts in the management of bisphosphonate associated atypical femoral fractures. World Journal of Orthopedics202112660\u2013671. (https:\/\/doi.org\/10.5312\/wjo.v12.i9.660)10.5312\/wjo.v12.i9.660"},{"key":"bib11","series-title":"New England Journal of Medicine","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1056\/NEJMc1612804","article-title":"GGPS1 mutation and atypical femoral fractures with bisphosphonates","volume":"376","author":"Roca-Ayats","year":"2017","unstructured":"Roca-Ayats NBalcells SGarcia-Giralt NFalc\u00f3-Mascar\u00f3 MMart\u00ednez-Gil NAbril JFUrreizti RDopazo JQuesada-G\u00f3mez JMNogu\u00e9s XGGPS1 mutation and atypical femoral fractures with bisphosphonates. New England Journal of Medicine20173761794\u20131795. (https:\/\/doi.org\/10.1056\/NEJMc1612804)10.1056\/NEJMc1612804"},{"key":"bib12","series-title":"Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.recot.2011.05.002","article-title":"Fracturas at\u00edpicas relacionadas con el uso prolongado de bifosfonatos. Estado de la situaci\u00f3n","volume":"55","author":"Caeiro-Rey","year":"2011","unstructured":"Caeiro-Rey JREtxebarria-Foronda IMesa-Ramos M. Fracturas at\u00edpicas relacionadas con el uso prolongado de bifosfonatos. Estado de la situaci\u00f3n. Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda201155392\u2013404. (https:\/\/doi.org\/10.1016\/j.recot.2011.05.002)10.1016\/j.recot.2011.05.002"},{"key":"bib13","series-title":"Journal of Bone and Mineral Research","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","unstructured":"Adler RAEl-Hajj Fuleihan GBauer DCCamacho PMClarke BLClines GACompston JEDrake MTEdwards BJFavus MJManaging osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research20163116\u201335. (https:\/\/doi.org\/10.1002\/jbmr.2708)10.1002\/jbmr.2708"},{"key":"bib14","series-title":"Journal of Bone Metabolism","doi-asserted-by":"publisher","first-page":"183","DOI":"10.11005\/jbm.2015.22.4.183","article-title":"Effect of teriparatide on healing of atypical femoral fractures: a systemic review","volume":"22","author":"Im","year":"2015","unstructured":"Im GILee SH. Effect of teriparatide on healing of atypical femoral fractures: a systemic review. Journal of Bone Metabolism201522183\u2013189. (https:\/\/doi.org\/10.11005\/jbm.2015.22.4.183)10.11005\/jbm.2015.22.4.183"},{"key":"bib15","series-title":"Journal of Bone and Mineral Research","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/jbmr.2818","article-title":"Incidence of atypical femur fractures in cancer patients: the MD Anderson Cancer Center experience","volume":"31","author":"Edwards","year":"2016","unstructured":"Edwards BJSun MWest DPGuindani MLin YHLu HHu MBarcenas CBird JFeng CIncidence of atypical femur fractures in cancer patients: the MD Anderson Cancer Center experience. Journal of Bone and Mineral Research2016311569\u20131576. (https:\/\/doi.org\/10.1002\/jbmr.2818)10.1002\/jbmr.2818"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2022\/1\/EDM22-0249.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2022\/1\/EDM22-0249.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2022\/1\/EDM22-0249.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:55Z","timestamp":1784555275000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":15,"URL":"https:\/\/doi.org\/10.1530\/edm-22-0249","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}